Part I: Checkpoint inhibitors in cancer therapy

Immunotherapy. 2016 Jun;8(6):675-6. doi: 10.2217/imt-2016-0051.
No abstract available

Publication types

  • Introductory Journal Article

MeSH terms

  • Antibodies, Blocking / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • B7-H1 Antigen / immunology
  • Clinical Trials as Topic
  • Drug-Related Side Effects and Adverse Reactions
  • Humans
  • Immune Evasion
  • Immunotherapy / methods*
  • Lymphocyte Activation
  • Neoplasms / immunology
  • Neoplasms / therapy*
  • Programmed Cell Death 1 Receptor / immunology
  • T-Lymphocytes / immunology*

Substances

  • Antibodies, Blocking
  • Antibodies, Monoclonal
  • B7-H1 Antigen
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor